REVEALED: 2 - The Real Truth

Aurora Cannabis: Q3 Earnings Insights

Aurora Cannabis (NASDAQ:ACB) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Aurora Cannabis missed estimated earnings by 83.33%, reporting an EPS of $-0.33 versus an estimate of $-0.18.

Benzinga · May 12, 2022

Preview: Aurora Cannabis's Earnings

Aurora Cannabis (NASDAQ:ACB) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Aurora Cannabis will report an earnings per share (EPS) of $-0.18.

Benzinga · May 11, 2022

Aurora Cannabis Completes Acquisition Of Thrive Cannabis

Aurora Cannabis Inc.

Benzinga · May 6, 2022

Aurora Cannabis Is Selling Stock To Pay Off Debt: Why Tilray And Canopy Could Be Next In Line

Earlier this month, Aurora Cannabis (NASDAQ: ABC) reported its second-quarter financial results, revealing a 10% decline in total net revenue, which totaled slig

Benzinga · Feb 28, 2022

Will Aurora Bounce Back? Analyst Explains Why The Stock Is A 'Long-Term Turnaround Story'

Aurora Cannabis (NASDAQ: ACB) (TSX:ACB) released its 

Benzinga · Feb 11, 2022

Aurora Cannabis Reports $75.1M Q2 Loss As Revenues Fall By 10 Percent

Aurora Cannabis (NASDAQ: ACB) (TSX: ACB) announced its financial and operational results for the second quarter fiscal 2022 ended December 31, 2021.

Benzinga · Feb 11, 2022

Aurora Cannabis: Q2 Earnings Insights

Aurora Cannabis (NASDAQ:ACB) reported its Q2 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · Feb 10, 2022

Aurora Cannabis' Reliva Expands Portfolio With New CBD Brand, KG7

CBD brand and subsidiary of Canadian cannabis giant Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB), Reliva,   announced the launch of KG7, a new high-quality CBD product line developed for adult consumers with an active lifestyle.

Benzinga · Feb 3, 2022